XML 19 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenue:    
Total revenue $ 33,173 $ 28,997
Cost of revenue:    
Cost of product revenue 14,820 12,697
Cost of service and other revenue 4,015 3,323
Amortization of Intangible Assets 183  
Total cost of revenue 19,018 16,020
Gross profit 14,155 12,977
Operating expense:    
Research and development 52,937 20,548
Sales, general and administrative 39,804 26,139
Change in fair value of contingent consideration (1,063)  
Total operating expense 91,678 46,687
Operating loss (77,523) (33,710)
(Loss)/Gain from Continuation Advances from Illumina   (52,000)
Interest expense (3,697) (1,789)
Other (expense) income, net (279) 64
Net loss (81,499) (87,435)
Other comprehensive loss:    
Unrealized loss on investments (2,998) (11)
Comprehensive loss $ (84,497) $ (87,446)
Net loss per share:    
Basic $ (0.37) $ (0.45)
Diluted $ (0.37) $ (0.45)
Weighted average shares outstanding used in calculating net loss per share:    
Basic 222,289 194,790
Diluted 222,289 194,790
Product [Member]    
Revenue:    
Total revenue $ 28,244 $ 25,303
Service and Other [Member]    
Revenue:    
Total revenue $ 4,929 $ 3,694